Searched for
RS SHANGHVI
Skyroot Aerospace, KreditBee among latest startups to enter unicorn clubIndia's startup scene is experiencing significant growth. Several new companies have achieved unicorn status, valued at over $1 billion. Sk...- Sun Pharma: How a small Kolkata trader became a global buyout artistSun Pharma, led by Dilip Shanghvi, is poised for its largest overseas acquisition, a $12.5 billion deal for Organon & Co. This move continu...
- Sun Pharma shares jump over 9% after firm announces $12 billion Organon acquisitionSun Pharmaceutical Industries' shares surged after announcing the $11.75 billion acquisition of US-based Organon & Co., a global leader in ...
- ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...
- Sun Pharma looks to outshine rival bids with $13 billion Organon offerSun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...
- Suzlon Energy shares fall over 3% after Dilip Shanghvi and Associates terminate 2020 pactShares of Suzlon Energy fell 3% to Rs 25 in Wednesday's trade on BSE after the Sun Pharma promoter Dilip Shanghvi and Associates decided to...
- Dilip Shanghvi & Associates terminate 2020 pact with Suzlon EnergyWith the termination of the agreement, the investor group's nominee director on Suzlon's board, Hiten Timbadia, has also resigned with effe...
- Sun Pharma promoters take a hit on personal investmentsSome of their biggest personal investments have been in power and real estate, and both sectors and their holdings have taken a beating, ac...
- Sun Pharma expects normalisation of India business in FY'19Sun Pharma MD Dilip Shanghvi said the government's enforced price cuts and policy changes are potential risk factors for the business.
- Pharma companies bat for settlement out of court on FDC issueThe high court, while lifting the ban on 344 drugs, had pulled up the government for haphazardly banning the drugs.
- Open offer to acquire 26 per cent stake in Suzlon draws poor responseUnder the open offer, Shanghvi and associates had to acquire 26 per cent stake for Rs 2,837 crore in the wind turbine maker.
- Dilip Shanghvi, promoters to make open offer to buy 26% Suzlon stakeDilip Shanghvi- controlled entities along with promoters of Suzlon will make an open offer worth Rs 2,837 crore to acquire 26% stake in the...
- Competition Commission approves Dilip Shanghvi's proposed Rs 1,800-crore deal with SuzlonThe deal, announced in February this year, would see Shanghvi acquiring at least 23 per cent stake in Suzlon which has been grappling with ...
- Sun Pharma surges on reports Shanghvi likely to buy partial stake of Daiichi in company; ends day flatSun Pharma rose as much as 2.8 per cent to hit its intraday high of Rs 1066.40 on the BSE, after ET NOW reported the story.
- Dilip Shanghvi in talks for a stake buy in ABG ShipyardTroubled shipbuilder ABG Shipyard is looking for a white knight and it's now pinning hopes on India's richest man Dlilip Shanghvi for a bai...
- Dilip Shanghvi, the self-made billionaire and Sun Pharma MD who hates limelightThe founder of Sun Pharma says far from being happy with the tag, he's not at all comfortable with the kind of attention it has triggered.
- Suzlon Energy rallies nearly 20% on Sun Pharma promoter's open offerSuzlon Energy last week signed definitive agreements with Dilip Shanghvi Family and Associates (DSA) for equity investments of Rs 1,800 cro...
- Dilip Shanghvi diversifies to expand his business, makes big investments in power and bankingThis weekend, Shanghvi announced a Rs 1,400-crore investment to pick up 23% stake in ailing renewable energy company Suzlon through DSA.
- Dilip Shanghvi, associates make open offer for 26% stake in SuzlonThe open offer price for 157.64 crore shares is Rs 18 per scrip, a total of about Rs 2,837.52 crore.
- ET Awards 2014: Sun Pharma's Dilip Shanghvi is Business Leader of the yearThe low-key, but persistent, managing director of Sun Pharmaceutical Industries is a self-made billionaire.
Load More
